These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 498166)

  • 1. Melphalan and 5-fluorouracil in advanced gastrointestinal carcinoma: a preliminary report.
    Gough IR; Furnival CM; Burnett W
    Cancer Treat Rev; 1979 Jun; 6 Suppl():127-9. PubMed ID: 498166
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
    Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
    Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
    Klaassen DJ; Boyes DA; Gerulath A; Levitt M; Miller AB; Pearson JG
    Cancer Treat Rep; 1979 Feb; 63(2):289-95. PubMed ID: 376135
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in advanced gastrointestinal cancer.
    Scanni A; Tomirotti M; Margulis A; Biraghi M; Curtarelli G
    Tumori; 1979 Feb; 65(1):111-7. PubMed ID: 87046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
    Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
    Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
    Nathanson L; Hall TC; Schilling A; Miller S
    Cancer Res; 1969 Feb; 29(2):419-25. PubMed ID: 4885390
    [No Abstract]   [Full Text] [Related]  

  • 9. Melphalan and methotrexate in advanced breast cancer.
    Priestman TJ; Salaman PF
    Cancer Treat Rep; 1978 Dec; 62(12):2111-2. PubMed ID: 751718
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of 5-FU melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM; Thynne GS; Burnett W
    Cancer Treat Rep; 1981; 65(7-8):735-6. PubMed ID: 7248993
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of 5-fluorouracil (5FU) treatment of malignant neoplasms].
    Singer Z; Kuśnierczykówna J; Iwanicka B
    Pol Tyg Lek; 1974 Jun; 29(24):1033-7. PubMed ID: 4845080
    [No Abstract]   [Full Text] [Related]  

  • 12. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
    Abdallah AM; Soukop M; Bell G; Calman KC
    Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
    Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
    Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
    Leff RS; Thompson JM; Johnson DB; Mosley KR; Daly MB; Knight WA; Ruxer RL; Messerschmidt GL
    J Clin Oncol; 1986 Nov; 4(11):1586-91. PubMed ID: 3534154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.
    Kane RD; Stocks LH; Paulson DF
    J Urol; 1977 Apr; 117(4):467-71. PubMed ID: 850320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.
    Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK
    Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled study with 1-phenylalanine mustard (l-PAM) and 5-fluorouracil (5-FU) plus or minus prednisone in advanced breast cancer.
    Rossi A; Brambilla C; Bonadonna G
    Tumori; 1976; 62(2):193-6. PubMed ID: 1006810
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
    Moertel CG
    JAMA; 1976 May; 235(19):2135-6. PubMed ID: 946546
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
    Kaufman S
    N Engl J Med; 1973 Jan; 288(4):199-201. PubMed ID: 4264581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.